Pyxis Oncology makes Thomas Civik permanent CEO
Pyxis Oncology appointed interim CEO Thomas Civik to a permanent CEO role. The clinical-stage company also named Civik board chair; he has served as interim CEO since February and on the board since 2021.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.